
Opinion|Videos|June 18, 2024
Bridging the Gap: Multidisciplinary Collaboration in Early Breast Cancer Care
The panelists share their concluding thoughts on the importance of collaboration between academic and community practices to achieve the best outcomes for their patients, which includes seeking second opinions and incorporating insights from tumor board discussions.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- When a new eBC product is approved, what is done prior to prepare from an operational standpoint?
- Are there instances when a new eBC product is approved and it’s not worth operationalizing?
- How can academic centers work efficiently with community practices in the management of patients with eBC?
- Scimeca: How might the approval of targeted therapies affect treatment paradigms for eBC?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
Environmental Factors Could Influence Type 1 Diabetes Risk in Children Through Epigenetic Changes
3
Targeting Mitochondrial Metabolism in Heart Failure: From Genetic Drivers to Fuel Modulation Therapies
4
Evolving Mortality Trends in Heart Failure and Vascular Disease: The Critical Role of Pharmacists in Addressing Cardiovascular Risk
5














































































































































































































